Emerging Biomarkers for Early Detection of Neurodegenerative Diseases in Aging

Abstract

Early diagnosis of neurodegenerative diseases is one of the most significant challenges in modern medicine. Diseases such as Alzheimer's, Parkinson's, and Amyotrophic Lateral Sclerosis (ALS) not only impose a heavy burden on affected individuals and their families but also incur substantial costs on healthcare systems. In this letter, we review recent research on emerging biomarkers for early detection of these diseases. Studies indicate that the use of emerging biomarkers can aid in early diagnosis and better management of neurodegenerative diseases. With further advancements in this field, it is expected that new diagnostic tools will be developed to improve the quality of life for individuals affected by these diseases.